BSE filing, NSE: SYNCOMF. Summary written from the filing by ALFA Finder's alert engine.
Syncom Formulation (India) Ltd: key numbers
- Share price
- ₹19.20
- Market cap
- ₹1,805 Cr
- Revenue (annual)
- ₹489.2 Cr
- Net profit (annual)
- ₹76.44 Cr
- P/E (TTM)
- 21.1×Sector 47.2×
- Promoter holding
- 50.57%+0.00% QoQ
- FII holding
- 2.23%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Syncom Formulation (India) Ltd
All →Syncom Formulation (India) Other Announcement
Syncom Formulations (India) Limited filed its quarterly shareholding pattern as per SEBI Regulation 31(1)(b) for the period ended September 30, 2026.
Syncom Formulation (India) Dividend
Syncom Formulations (India) Ltd shareholders approved a final dividend of Rs. 0.10 per equity share at the 38th AGM, totaling Rs. 9.40 Crore.
- Value
- ₹9.40 Cr
Syncom Formulation (India) Management Change
Syncom Formulations (India) Limited announced the appointments of Rahul Vijay Bankda as Managing Director and Rinki Ankit Bankda as Whole Time Director. Ruchi Jindal was reappointed.
Syncom Formulation (India) Annual General Meeting
Syncom Formulations (India) Limited held its 38th Annual General Meeting on September 30, 2026, via video conferencing to transact various ordinary and special business items.
Syncom Formulation (India) Other Announcement
Syncom Formulations' promoters have voluntarily waived their right to the proposed final dividend of ₹0.10 per share. This waiver reduces total dividend payout obligations.
- Value
- ₹4.75 Cr
Syncom Formulation (India) Other Announcement
Syncom Formulations fixed 23 Sep 2026 as record date for a proposed 10% dividend (Rs.0.10/share) pending AGM approval. The 38th AGM is scheduled for 30 Sep 2026.
Other board meeting date announcements
All →Pan Electronics India Board Meeting Date
PAN Electronics (India) intimated a board meeting on 13 November 2026 to consider unaudited standalone half-yearly financial results for the period ended September 2026. The trading window closes from 1 October to 18 November 2026.
Mangalam Industrial Finance Board Meeting Date
Mangalam Industrial Finance scheduled a board meeting for November 6, 2026. It will consider unaudited Q2 and H1 FY27 standalone results.
Olympic Cards Board Meeting Date
Olympic Cards schedules a board meeting on 12 November 2026 to consider unaudited quarterly results. The trading window stays closed until results are declared.
Vaishali Pharma Board Meeting Date
Vaishali Pharma has scheduled an audit committee meeting for 5 November 2026. Proposed agenda includes a fund raise via preferential issue and an increase in authorised capital.
Ventura Textiles Board Meeting Date
Ventura Textiles scheduled a board meeting for 9 November 2026 to consider unaudited results and new business strategy. The agenda is proposed until the meeting is held.
Sampre Nutritions Board Meeting Date
Sampre Nutritions has scheduled a board meeting on 6 November 2026 to consider its unaudited Q2 FY27 standalone and consolidated results. The filing is an advance notice with no results figures yet disclosed.